Drawing for REACH

USPTO serial 79461697

REACH

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with REACH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for use in biotechnology research; nucleic acids for scientific or research purposes; oligonucleotides for scientific or research purposes.ACTIVE—
005Pharmaceutical preparations for the treatment and prevention of genetic diseases and neurological disorders; oligonucleotides for medical purposes, in particular for the treatment and prevention of genetic diseases and neurological disorders and for use in rna modulation.ACTIVE—
042Scientific and technological research in the field of biotechnology; biotechnological research relating to the central nervous system and neurological disorders; research and development of oligonucleotides, in particular for the treatment and prevention of genetic diseases and neurological disorders and for use in RNA modulation; research, development and testing of pharmaceutical and biochemical products, in particular for use in medicines; research, development and testing of medicines; drug discovery services; identification of new drug targets.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 29, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 29, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 29, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance